Bert Binas | CSO
3H Bio Co., Ltd.
Dr. Binas has a professional background in lipid metabolism, metabolic physiology, and stem cell biology. He graduated with a bachelor’s degree in Biophysics from Pirogov Russian National Research Medical University, then earned his PhD in Cellular Biochemistry at the Central Institute for Molecular Biology (Germany) and completed postdoctoral training in transgenics and gene targeting at the Roslin Institute (UK) and the Max Delbrück Center for Molecular Medicine (Germany). He subsequently served as an Associate Professor at Texas A&M University (USA), focusing on metabolic physiology, and later as a Full Professor at Hanyang University (Korea), where his work centered on stem cell biology until his regular academic retirement. Seeking continued challenges, Dr. Binas joined 3H Bio Co., Ltd. (Korea) in 2023 as Chief Scientific Officer, where he now focuses on immune modulation of systemic metabolism, extending his expertise into immunology, vaccinology, and translational clinical development.
Appearances:
Pre-Congress Workshops - Monday 30th March @ 11:30
UNCONVENTIONAL VACCINES: OBESITY, ATHEROSCLEROSIS, AND ALZHEIMER’S DISEASE
This workshop explores the cutting edge of vaccinology, moving beyond infectious diseases to tackle the world’s most pressing chronic and metabolic conditions. Hosted by 3H Bio, the session brings together global pioneers to discuss how targeted immunological interventions can arrest the progression of atherosclerosis, Alzheimer’s, and obesity.
Attendees will gain insights into:
- Clinical breakthroughs in Tau-targeting vaccines for neurodegeneration.
- Novel platforms like mimotope vaccines for metabolic regulation.
- Translational challenges of moving unconventional vaccines from immunological theory to human clinical trials.
Join us to discover how the next generation of vaccines is being engineered to treat non-communicable diseases and reshape the future of preventative medicine.
11.30am Chair’s opening remarks:
Dr Kevin Killeen, President & CEO, 2K Biologics
11:30 Atherosclerosis Vaccination: From Immunological Concepts to Clinical Translation
Dr Jan Nilsson, Professor of Medicine, Lund University
11:50 Advax-CpG adjuvanted Alzheimer’s vaccines
Dr Nikolai Petrovsky, Founder & Research Director, Vaxine
12:10 3HOTP – A mimotope vaccine with anti-obesity and broader metabolic benefits
Dr Bert Binas, CSO, 3H Bio
12:30 Closing Panel Discussion – Common themes and challenges in unconventional vaccine development
Pre-Congress Workshops - Monday 30th March @ 11:30
UNCONVENTIONAL VACCINES: OBESITY, ATHEROSCLEROSIS, AND ALZHEIMER’S DISEASE
This workshop explores the cutting edge of vaccinology, moving beyond infectious diseases to tackle the world’s most pressing chronic and metabolic conditions. Hosted by 3H Bio, the session brings together global pioneers to discuss how targeted immunological interventions can arrest the progression of atherosclerosis, Alzheimer’s, and obesity.
Attendees will gain insights into:
- Clinical breakthroughs in Tau-targeting vaccines for neurodegeneration.
- Novel platforms like mimotope vaccines for metabolic regulation.
- Translational challenges of moving unconventional vaccines from immunological theory to human clinical trials.
Join us to discover how the next generation of vaccines is being engineered to treat non-communicable diseases and reshape the future of preventative medicine.
11.30am Chair’s opening remarks:
Dr Kevin Killeen, President & CEO, 2K Biologics
11:30 Atherosclerosis Vaccination: From Immunological Concepts to Clinical Translation
Dr Jan Nilsson, Professor of Medicine, Lund University
11:50 Advax-CpG adjuvanted Alzheimer’s vaccines
Dr Nikolai Petrovsky, Founder & Research Director, Vaxine
12:10 3HOTP – A mimotope vaccine with anti-obesity and broader metabolic benefits
Dr Bert Binas, CSO, 3H Bio
12:30 Closing Panel Discussion – Common themes and challenges in unconventional vaccine development
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events